Specification

MSDS

TSE / BSE Statement

Retest Statement

• synthesis, ethyl, acid ethyl, dpp-4, potent, quinoline-3-carboxylic acid, esters, ethyl esters, bromides, inhibition, structure, type 2 diabetes, diabetes, dipeptidyl peptidase, hiv-1 replication, chemistry, replication, arylmethyl, hiv-1, substituted, ccr5 antagonists, discovery, glucose, synthetic analogs, dipeptidyl, inhibitor, reaction, orally, allylation, Show more, organic allyl, active, antagonists, mixture, peptidase, azides, treatment, compound, synthetic, analogs, process, cyclization, asymmetric, profile, antitumor agents, inhibitors, heteroarylpiperazines, iminium, synthesized, homoallylic, macrocyclic, fatty, dosing, antitumor, mechanism, amide, ammonium, phenyl, plasma, mononuclear, organic chemistry, mononuclear cells, selectivity, valilactone, efficient, nature, potent inhibitors, ethanol, compounds, cyclopropanol, preclinical, potency, phenyl ring, functionalized, interaction, acid ethyl ester, co-crystal, agents, ammonium chloride, glucose levels, high diastereoselectivity, refluxing, chloride, reductive, hypoglycemia, plasma glucose levels, intermediates, ethyl ester, potent inhibition, pyrazole, ester, homoallylic alcohols, bicyclic, inhibited, express, levels, co-crystal structure, plasma glucose, blood mononuclear cells, oral glucose, tetrahydrofuran, alcohols, low risk, japan, binding, proline, x-ray, oral dosing, biomolecular, boosted, biomolecular chemistry, significantly, dpp-4 inhibitor, blood mononuclear, asymmetric synthesis, diastereoselectivity, subsite, blood, Show less